Company Search:
Advanced Search
Sponsored Links
Indofarma (Persero) Tbk PT Company Snapshot
Indofarma (Persero) Tbk PT operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Indofarma (Persero) Tbk PT with three other pharmaceutical manufacturers in Asia: Jacobson Pharma Corporation Ltd of Hong Kong (2015 sales of 947.59 million Hong Kong Dollars [US$122.10 million] of which 89% was Generic drugs), Natco Pharma Limited of India (8.25 billion Indian Rupees [US$123.21 million] of which 52% was Finished Dosage Formulations), and Daehwa Pharmaceutical Company Limited which is based in South Korea (139.08 billion Korean Won [US$121.69 million] ).

Sales Analysis. During the year ended December of 2015, sales at Indofarma (Persero) Tbk PT were 1.62 trillion Indonesian Rupiahs (US$121.32 million). This is an increase of 17.4% versus 2014, when the company's sales were 1.38 trillion Indonesian Rupiahs. This was the third consecutive year of growth at Indofarma (Persero) Tbk PT.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Indofarma (Persero) Tbk PT
  Stock Performance Chart for Indofarma (Persero) Tbk PT
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 2,420.00
(Figures in Indonesian Rupiahs)
1 Week -2.4%   13 Weeks -28.8%  
4 Weeks -35.8%   52 Weeks 661.0%  
Indofarma (Persero) Tbk PT Key Data:
  Ticker: INAF Country: Indonesia
  Exchanges: JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,621,898,667,657
(Year Ending Jan 2016).
Employees: 1,804
  Currency: Indonesian Rupiahs Market Cap: 7,500,227,350,000
  Fiscal Yr Ends: December Shares Outstanding: 3,099,267,500
  Share Type: Ordinary Closely Held Shares: 2,500,000,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.